Work

Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting β agonist treatment in a multiethnic asthma population: a genetic study

Year: 2014

Type: article

Study design: Observational Study

Source: The Lancet Respiratory Medicine

DOI: 10.1016/s2213-2600(13)70289-3

Authors: Victor E Ortega, Gregory A Hawkins, Wendy C Moore, Annette T Hastie, Elizabeth J Ampleford, William W Busse, Mario Castro, Domingo Chardon, Serpil C Erzurum, Elliot Israel, Federico Montealegre, Sally E Wenzel, Stephen P Peters, Deborah A Meyers, Eugene R Bleecker

Institutions: Wake Forest University Health Sciences, Wake Forest University, University of Wisconsin–Madison, Washington University in St. Louis, Hospital Episcopal San Lucas, Cleveland Clinic, Cleveland Clinic Research, Brigham and Women's Hospital, Harvard University, University of Pittsburgh

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Wake Forest University, National Institutes of Health, Johnson and Johnson, National Heart, Lung, and Blood Institute, National Institute of Nursing Research

Awards: Genetic studies in difficult to treat asthma: TENOR, Longitudinal Phenomics and Genetics of Severe Asthma, Pharmacogenetics of Asthma Treatment, Linking Genetics, Genomics and Phenomics to Better Understand Asthma Severity, G256204710, Scholars' Program in the Genetics and Genomics of Lung Diseases, The Genetic Epidemiology of Asthma in Costa Rica, Atlantic Coast Consortium for Asthma (ACC-A) AsthmaNet Clinical Site, Genetics of lung function and asthma severity in African Americans, G7206313631, G8991194850

OpenAlex ID: W2126279305

FWCI: 11

Cites: 51

Cited by: 109

Related to: 10